Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption

Plasmacytoid dendritic cells (pDCs) are robust producers of IFNα and one of the first immune cells to respond to SIV infection. To elucidate responses to early HIV-1 replication, we studied blood pDCs in 29 HIV-infected participants who initiated antiretroviral therapy during acute infection and und...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2020-06, Vol.130 (6), p.2845-2858
Hauptverfasser: Mitchell, Julie L, Takata, Hiroshi, Muir, Roshell, Colby, Donn J, Kroon, Eugène, Crowell, Trevor A, Sacdalan, Carlo, Pinyakorn, Suteeraporn, Puttamaswin, Suwanna, Benjapornpong, Khunthalee, Trichavaroj, Rapee, Tressler, Randall L, Fox, Lawrence, Polonis, Victoria R, Bolton, Diane L, Maldarelli, Frank, Lewin, Sharon R, Haddad, Elias K, Phanuphak, Praphan, Robb, Merlin L, Michael, Nelson L, de Souza, Mark, Phanuphak, Nittaya, Ananworanich, Jintanat, Trautmann, Lydie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2858
container_issue 6
container_start_page 2845
container_title The Journal of clinical investigation
container_volume 130
creator Mitchell, Julie L
Takata, Hiroshi
Muir, Roshell
Colby, Donn J
Kroon, Eugène
Crowell, Trevor A
Sacdalan, Carlo
Pinyakorn, Suteeraporn
Puttamaswin, Suwanna
Benjapornpong, Khunthalee
Trichavaroj, Rapee
Tressler, Randall L
Fox, Lawrence
Polonis, Victoria R
Bolton, Diane L
Maldarelli, Frank
Lewin, Sharon R
Haddad, Elias K
Phanuphak, Praphan
Robb, Merlin L
Michael, Nelson L
de Souza, Mark
Phanuphak, Nittaya
Ananworanich, Jintanat
Trautmann, Lydie
description Plasmacytoid dendritic cells (pDCs) are robust producers of IFNα and one of the first immune cells to respond to SIV infection. To elucidate responses to early HIV-1 replication, we studied blood pDCs in 29 HIV-infected participants who initiated antiretroviral therapy during acute infection and underwent analytic treatment interruption (ATI). We observed an increased frequency of partially activated pDCs in the blood before detection of HIV RNA. Concurrent with peak pDC frequency, we detected a transient decline in the ability of pDCs to produce IFNα in vitro, which correlated with decreased phosphorylation of IFN regulatory factory 7 (IRF7) and NF-κB. The levels of phosphorylated IRF7 and NF-κB inversely correlated with plasma IFNα2 levels, implying that pDCs were refractory to in vitro stimulation after IFNα production in vivo. After ATI, decreased expression of IFN genes in pDCs inversely correlated with the time to viral detection, suggesting that pDC IFN loss is part of an effective early immune response. These data from a limited cohort provide a critical first step in understanding the earliest immune response to HIV-1 and suggest that changes in blood pDC frequency and function can be used as an indicator of viral replication before detectable plasma viremia.
doi_str_mv 10.1172/JCI130597
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7260031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A627278054</galeid><sourcerecordid>A627278054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c647t-3f97117092ae2f475cc2fa76cfc1b6d63168b60ff5afe2df8a0f9258efdfbd853</originalsourceid><addsrcrecordid>eNqNkl1rFDEUhgdR7Fq98A_IgCB6MTUfk8nMjVAWtSuFih-9DZnMyW5KJtkmmWr_vRmsa1f2QnIRSJ7zno_3FMVzjE4w5uTtp-UKU8Q6_qBYYMbaqiW0fVgsECK46jhtj4onMV4hhOua1Y-LI0oQ5hx1i2L8bGUcpbpN3gzlAG4IJhlVKrA2lhFchPJsdVkG2FqjZDLelT1oHyDDCVSSvYXyxgQYjSy1t9b_MG5dpgAyjeBSaVyCEKbtHPq0eKSljfDs7j4uvn94_215Vp1ffFwtT88r1dQ8VVR3PDeGOiKB6JozpYiWvFFa4b4ZGoqbtm-Q1kxqIINuJdIdYS3oQfdDy-hx8e637nbqRxhUriNIK7bBjDLcCi-N2P9xZiPW_kZw0iBEcRZ4fScQ_PUEMYnRxHkm0oGfoiCUYUaauqYZffkPeuWn4HJ7gtR54IThlv-l1tKCME77nFfNouK0IZzwFrE6U9UBag0OcpHegTb5eY8_OcDnM2Q71MGAN3sBmUnwM63lFKNYff3y_-zF5T776h67AWnTJno7zabHg6Iq-BgD6J0pGIl5mcVumTP74r6LO_LP9tJfMGTtmw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414425187</pqid></control><display><type>article</type><title>Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Mitchell, Julie L ; Takata, Hiroshi ; Muir, Roshell ; Colby, Donn J ; Kroon, Eugène ; Crowell, Trevor A ; Sacdalan, Carlo ; Pinyakorn, Suteeraporn ; Puttamaswin, Suwanna ; Benjapornpong, Khunthalee ; Trichavaroj, Rapee ; Tressler, Randall L ; Fox, Lawrence ; Polonis, Victoria R ; Bolton, Diane L ; Maldarelli, Frank ; Lewin, Sharon R ; Haddad, Elias K ; Phanuphak, Praphan ; Robb, Merlin L ; Michael, Nelson L ; de Souza, Mark ; Phanuphak, Nittaya ; Ananworanich, Jintanat ; Trautmann, Lydie</creator><creatorcontrib>Mitchell, Julie L ; Takata, Hiroshi ; Muir, Roshell ; Colby, Donn J ; Kroon, Eugène ; Crowell, Trevor A ; Sacdalan, Carlo ; Pinyakorn, Suteeraporn ; Puttamaswin, Suwanna ; Benjapornpong, Khunthalee ; Trichavaroj, Rapee ; Tressler, Randall L ; Fox, Lawrence ; Polonis, Victoria R ; Bolton, Diane L ; Maldarelli, Frank ; Lewin, Sharon R ; Haddad, Elias K ; Phanuphak, Praphan ; Robb, Merlin L ; Michael, Nelson L ; de Souza, Mark ; Phanuphak, Nittaya ; Ananworanich, Jintanat ; Trautmann, Lydie ; RV397, RV411, and RV254 Study Groups</creatorcontrib><description>Plasmacytoid dendritic cells (pDCs) are robust producers of IFNα and one of the first immune cells to respond to SIV infection. To elucidate responses to early HIV-1 replication, we studied blood pDCs in 29 HIV-infected participants who initiated antiretroviral therapy during acute infection and underwent analytic treatment interruption (ATI). We observed an increased frequency of partially activated pDCs in the blood before detection of HIV RNA. Concurrent with peak pDC frequency, we detected a transient decline in the ability of pDCs to produce IFNα in vitro, which correlated with decreased phosphorylation of IFN regulatory factory 7 (IRF7) and NF-κB. The levels of phosphorylated IRF7 and NF-κB inversely correlated with plasma IFNα2 levels, implying that pDCs were refractory to in vitro stimulation after IFNα production in vivo. After ATI, decreased expression of IFN genes in pDCs inversely correlated with the time to viral detection, suggesting that pDC IFN loss is part of an effective early immune response. These data from a limited cohort provide a critical first step in understanding the earliest immune response to HIV-1 and suggest that changes in blood pDC frequency and function can be used as an indicator of viral replication before detectable plasma viremia.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI130597</identifier><identifier>PMID: 32017709</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Adult ; Antiretroviral drugs ; Antiretroviral therapy ; Biomedical research ; Blood ; Cytokines ; Dendritic cells ; Dendritic Cells - immunology ; Dendritic Cells - pathology ; Drug therapy ; Female ; Health aspects ; Highly active antiretroviral therapy ; HIV ; HIV Infections - immunology ; HIV Infections - pathology ; HIV Infections - therapy ; HIV tests ; HIV-1 - physiology ; Human immunodeficiency virus ; Humans ; Infection ; Infections ; Interferon regulatory factor 7 ; Interferon Regulatory Factor-7 - immunology ; Interferon-alpha - immunology ; Male ; Maraviroc ; NF-kappa B - immunology ; NF-κB protein ; Phosphorylation ; Plasma ; Replication ; Ribonucleic acid ; RNA ; Scientific equipment industry ; Studies ; Viral infections ; Viremia ; Viremia - immunology ; Viremia - pathology ; Viremia - therapy ; Virus replication ; Virus Replication - immunology ; Vorinostat ; α-Interferon</subject><ispartof>The Journal of clinical investigation, 2020-06, Vol.130 (6), p.2845-2858</ispartof><rights>COPYRIGHT 2020 American Society for Clinical Investigation</rights><rights>Copyright American Society for Clinical Investigation Jun 2020</rights><rights>2020 American Society for Clinical Investigation 2020 American Society for Clinical Investigation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c647t-3f97117092ae2f475cc2fa76cfc1b6d63168b60ff5afe2df8a0f9258efdfbd853</citedby><cites>FETCH-LOGICAL-c647t-3f97117092ae2f475cc2fa76cfc1b6d63168b60ff5afe2df8a0f9258efdfbd853</cites><orcidid>0000-0003-1369-3224 ; 0000-0003-2226-7825 ; 0000-0001-5947-265X ; 0000-0003-1457-6919 ; 0000-0003-3931-5926 ; 0000-0002-3062-5250 ; 0000-0003-3949-9649 ; 0000-0001-5882-5548 ; 0000-0003-1897-499X ; 0000-0002-5839-4837 ; 0000-0003-3880-4381 ; 0000-0001-6924-4300 ; 0000-0002-0036-3165 ; 0000-0002-3012-0009</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260031/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260031/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32017709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mitchell, Julie L</creatorcontrib><creatorcontrib>Takata, Hiroshi</creatorcontrib><creatorcontrib>Muir, Roshell</creatorcontrib><creatorcontrib>Colby, Donn J</creatorcontrib><creatorcontrib>Kroon, Eugène</creatorcontrib><creatorcontrib>Crowell, Trevor A</creatorcontrib><creatorcontrib>Sacdalan, Carlo</creatorcontrib><creatorcontrib>Pinyakorn, Suteeraporn</creatorcontrib><creatorcontrib>Puttamaswin, Suwanna</creatorcontrib><creatorcontrib>Benjapornpong, Khunthalee</creatorcontrib><creatorcontrib>Trichavaroj, Rapee</creatorcontrib><creatorcontrib>Tressler, Randall L</creatorcontrib><creatorcontrib>Fox, Lawrence</creatorcontrib><creatorcontrib>Polonis, Victoria R</creatorcontrib><creatorcontrib>Bolton, Diane L</creatorcontrib><creatorcontrib>Maldarelli, Frank</creatorcontrib><creatorcontrib>Lewin, Sharon R</creatorcontrib><creatorcontrib>Haddad, Elias K</creatorcontrib><creatorcontrib>Phanuphak, Praphan</creatorcontrib><creatorcontrib>Robb, Merlin L</creatorcontrib><creatorcontrib>Michael, Nelson L</creatorcontrib><creatorcontrib>de Souza, Mark</creatorcontrib><creatorcontrib>Phanuphak, Nittaya</creatorcontrib><creatorcontrib>Ananworanich, Jintanat</creatorcontrib><creatorcontrib>Trautmann, Lydie</creatorcontrib><creatorcontrib>RV397, RV411, and RV254 Study Groups</creatorcontrib><title>Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Plasmacytoid dendritic cells (pDCs) are robust producers of IFNα and one of the first immune cells to respond to SIV infection. To elucidate responses to early HIV-1 replication, we studied blood pDCs in 29 HIV-infected participants who initiated antiretroviral therapy during acute infection and underwent analytic treatment interruption (ATI). We observed an increased frequency of partially activated pDCs in the blood before detection of HIV RNA. Concurrent with peak pDC frequency, we detected a transient decline in the ability of pDCs to produce IFNα in vitro, which correlated with decreased phosphorylation of IFN regulatory factory 7 (IRF7) and NF-κB. The levels of phosphorylated IRF7 and NF-κB inversely correlated with plasma IFNα2 levels, implying that pDCs were refractory to in vitro stimulation after IFNα production in vivo. After ATI, decreased expression of IFN genes in pDCs inversely correlated with the time to viral detection, suggesting that pDC IFN loss is part of an effective early immune response. These data from a limited cohort provide a critical first step in understanding the earliest immune response to HIV-1 and suggest that changes in blood pDC frequency and function can be used as an indicator of viral replication before detectable plasma viremia.</description><subject>Adult</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Biomedical research</subject><subject>Blood</subject><subject>Cytokines</subject><subject>Dendritic cells</subject><subject>Dendritic Cells - immunology</subject><subject>Dendritic Cells - pathology</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Health aspects</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - pathology</subject><subject>HIV Infections - therapy</subject><subject>HIV tests</subject><subject>HIV-1 - physiology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infection</subject><subject>Infections</subject><subject>Interferon regulatory factor 7</subject><subject>Interferon Regulatory Factor-7 - immunology</subject><subject>Interferon-alpha - immunology</subject><subject>Male</subject><subject>Maraviroc</subject><subject>NF-kappa B - immunology</subject><subject>NF-κB protein</subject><subject>Phosphorylation</subject><subject>Plasma</subject><subject>Replication</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>Scientific equipment industry</subject><subject>Studies</subject><subject>Viral infections</subject><subject>Viremia</subject><subject>Viremia - immunology</subject><subject>Viremia - pathology</subject><subject>Viremia - therapy</subject><subject>Virus replication</subject><subject>Virus Replication - immunology</subject><subject>Vorinostat</subject><subject>α-Interferon</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkl1rFDEUhgdR7Fq98A_IgCB6MTUfk8nMjVAWtSuFih-9DZnMyW5KJtkmmWr_vRmsa1f2QnIRSJ7zno_3FMVzjE4w5uTtp-UKU8Q6_qBYYMbaqiW0fVgsECK46jhtj4onMV4hhOua1Y-LI0oQ5hx1i2L8bGUcpbpN3gzlAG4IJhlVKrA2lhFchPJsdVkG2FqjZDLelT1oHyDDCVSSvYXyxgQYjSy1t9b_MG5dpgAyjeBSaVyCEKbtHPq0eKSljfDs7j4uvn94_215Vp1ffFwtT88r1dQ8VVR3PDeGOiKB6JozpYiWvFFa4b4ZGoqbtm-Q1kxqIINuJdIdYS3oQfdDy-hx8e637nbqRxhUriNIK7bBjDLcCi-N2P9xZiPW_kZw0iBEcRZ4fScQ_PUEMYnRxHkm0oGfoiCUYUaauqYZffkPeuWn4HJ7gtR54IThlv-l1tKCME77nFfNouK0IZzwFrE6U9UBag0OcpHegTb5eY8_OcDnM2Q71MGAN3sBmUnwM63lFKNYff3y_-zF5T776h67AWnTJno7zabHg6Iq-BgD6J0pGIl5mcVumTP74r6LO_LP9tJfMGTtmw</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Mitchell, Julie L</creator><creator>Takata, Hiroshi</creator><creator>Muir, Roshell</creator><creator>Colby, Donn J</creator><creator>Kroon, Eugène</creator><creator>Crowell, Trevor A</creator><creator>Sacdalan, Carlo</creator><creator>Pinyakorn, Suteeraporn</creator><creator>Puttamaswin, Suwanna</creator><creator>Benjapornpong, Khunthalee</creator><creator>Trichavaroj, Rapee</creator><creator>Tressler, Randall L</creator><creator>Fox, Lawrence</creator><creator>Polonis, Victoria R</creator><creator>Bolton, Diane L</creator><creator>Maldarelli, Frank</creator><creator>Lewin, Sharon R</creator><creator>Haddad, Elias K</creator><creator>Phanuphak, Praphan</creator><creator>Robb, Merlin L</creator><creator>Michael, Nelson L</creator><creator>de Souza, Mark</creator><creator>Phanuphak, Nittaya</creator><creator>Ananworanich, Jintanat</creator><creator>Trautmann, Lydie</creator><general>American Society for Clinical Investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1369-3224</orcidid><orcidid>https://orcid.org/0000-0003-2226-7825</orcidid><orcidid>https://orcid.org/0000-0001-5947-265X</orcidid><orcidid>https://orcid.org/0000-0003-1457-6919</orcidid><orcidid>https://orcid.org/0000-0003-3931-5926</orcidid><orcidid>https://orcid.org/0000-0002-3062-5250</orcidid><orcidid>https://orcid.org/0000-0003-3949-9649</orcidid><orcidid>https://orcid.org/0000-0001-5882-5548</orcidid><orcidid>https://orcid.org/0000-0003-1897-499X</orcidid><orcidid>https://orcid.org/0000-0002-5839-4837</orcidid><orcidid>https://orcid.org/0000-0003-3880-4381</orcidid><orcidid>https://orcid.org/0000-0001-6924-4300</orcidid><orcidid>https://orcid.org/0000-0002-0036-3165</orcidid><orcidid>https://orcid.org/0000-0002-3012-0009</orcidid></search><sort><creationdate>20200601</creationdate><title>Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption</title><author>Mitchell, Julie L ; Takata, Hiroshi ; Muir, Roshell ; Colby, Donn J ; Kroon, Eugène ; Crowell, Trevor A ; Sacdalan, Carlo ; Pinyakorn, Suteeraporn ; Puttamaswin, Suwanna ; Benjapornpong, Khunthalee ; Trichavaroj, Rapee ; Tressler, Randall L ; Fox, Lawrence ; Polonis, Victoria R ; Bolton, Diane L ; Maldarelli, Frank ; Lewin, Sharon R ; Haddad, Elias K ; Phanuphak, Praphan ; Robb, Merlin L ; Michael, Nelson L ; de Souza, Mark ; Phanuphak, Nittaya ; Ananworanich, Jintanat ; Trautmann, Lydie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c647t-3f97117092ae2f475cc2fa76cfc1b6d63168b60ff5afe2df8a0f9258efdfbd853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Biomedical research</topic><topic>Blood</topic><topic>Cytokines</topic><topic>Dendritic cells</topic><topic>Dendritic Cells - immunology</topic><topic>Dendritic Cells - pathology</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Health aspects</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - pathology</topic><topic>HIV Infections - therapy</topic><topic>HIV tests</topic><topic>HIV-1 - physiology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infection</topic><topic>Infections</topic><topic>Interferon regulatory factor 7</topic><topic>Interferon Regulatory Factor-7 - immunology</topic><topic>Interferon-alpha - immunology</topic><topic>Male</topic><topic>Maraviroc</topic><topic>NF-kappa B - immunology</topic><topic>NF-κB protein</topic><topic>Phosphorylation</topic><topic>Plasma</topic><topic>Replication</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>Scientific equipment industry</topic><topic>Studies</topic><topic>Viral infections</topic><topic>Viremia</topic><topic>Viremia - immunology</topic><topic>Viremia - pathology</topic><topic>Viremia - therapy</topic><topic>Virus replication</topic><topic>Virus Replication - immunology</topic><topic>Vorinostat</topic><topic>α-Interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mitchell, Julie L</creatorcontrib><creatorcontrib>Takata, Hiroshi</creatorcontrib><creatorcontrib>Muir, Roshell</creatorcontrib><creatorcontrib>Colby, Donn J</creatorcontrib><creatorcontrib>Kroon, Eugène</creatorcontrib><creatorcontrib>Crowell, Trevor A</creatorcontrib><creatorcontrib>Sacdalan, Carlo</creatorcontrib><creatorcontrib>Pinyakorn, Suteeraporn</creatorcontrib><creatorcontrib>Puttamaswin, Suwanna</creatorcontrib><creatorcontrib>Benjapornpong, Khunthalee</creatorcontrib><creatorcontrib>Trichavaroj, Rapee</creatorcontrib><creatorcontrib>Tressler, Randall L</creatorcontrib><creatorcontrib>Fox, Lawrence</creatorcontrib><creatorcontrib>Polonis, Victoria R</creatorcontrib><creatorcontrib>Bolton, Diane L</creatorcontrib><creatorcontrib>Maldarelli, Frank</creatorcontrib><creatorcontrib>Lewin, Sharon R</creatorcontrib><creatorcontrib>Haddad, Elias K</creatorcontrib><creatorcontrib>Phanuphak, Praphan</creatorcontrib><creatorcontrib>Robb, Merlin L</creatorcontrib><creatorcontrib>Michael, Nelson L</creatorcontrib><creatorcontrib>de Souza, Mark</creatorcontrib><creatorcontrib>Phanuphak, Nittaya</creatorcontrib><creatorcontrib>Ananworanich, Jintanat</creatorcontrib><creatorcontrib>Trautmann, Lydie</creatorcontrib><creatorcontrib>RV397, RV411, and RV254 Study Groups</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mitchell, Julie L</au><au>Takata, Hiroshi</au><au>Muir, Roshell</au><au>Colby, Donn J</au><au>Kroon, Eugène</au><au>Crowell, Trevor A</au><au>Sacdalan, Carlo</au><au>Pinyakorn, Suteeraporn</au><au>Puttamaswin, Suwanna</au><au>Benjapornpong, Khunthalee</au><au>Trichavaroj, Rapee</au><au>Tressler, Randall L</au><au>Fox, Lawrence</au><au>Polonis, Victoria R</au><au>Bolton, Diane L</au><au>Maldarelli, Frank</au><au>Lewin, Sharon R</au><au>Haddad, Elias K</au><au>Phanuphak, Praphan</au><au>Robb, Merlin L</au><au>Michael, Nelson L</au><au>de Souza, Mark</au><au>Phanuphak, Nittaya</au><au>Ananworanich, Jintanat</au><au>Trautmann, Lydie</au><aucorp>RV397, RV411, and RV254 Study Groups</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>130</volume><issue>6</issue><spage>2845</spage><epage>2858</epage><pages>2845-2858</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Plasmacytoid dendritic cells (pDCs) are robust producers of IFNα and one of the first immune cells to respond to SIV infection. To elucidate responses to early HIV-1 replication, we studied blood pDCs in 29 HIV-infected participants who initiated antiretroviral therapy during acute infection and underwent analytic treatment interruption (ATI). We observed an increased frequency of partially activated pDCs in the blood before detection of HIV RNA. Concurrent with peak pDC frequency, we detected a transient decline in the ability of pDCs to produce IFNα in vitro, which correlated with decreased phosphorylation of IFN regulatory factory 7 (IRF7) and NF-κB. The levels of phosphorylated IRF7 and NF-κB inversely correlated with plasma IFNα2 levels, implying that pDCs were refractory to in vitro stimulation after IFNα production in vivo. After ATI, decreased expression of IFN genes in pDCs inversely correlated with the time to viral detection, suggesting that pDC IFN loss is part of an effective early immune response. These data from a limited cohort provide a critical first step in understanding the earliest immune response to HIV-1 and suggest that changes in blood pDC frequency and function can be used as an indicator of viral replication before detectable plasma viremia.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>32017709</pmid><doi>10.1172/JCI130597</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-1369-3224</orcidid><orcidid>https://orcid.org/0000-0003-2226-7825</orcidid><orcidid>https://orcid.org/0000-0001-5947-265X</orcidid><orcidid>https://orcid.org/0000-0003-1457-6919</orcidid><orcidid>https://orcid.org/0000-0003-3931-5926</orcidid><orcidid>https://orcid.org/0000-0002-3062-5250</orcidid><orcidid>https://orcid.org/0000-0003-3949-9649</orcidid><orcidid>https://orcid.org/0000-0001-5882-5548</orcidid><orcidid>https://orcid.org/0000-0003-1897-499X</orcidid><orcidid>https://orcid.org/0000-0002-5839-4837</orcidid><orcidid>https://orcid.org/0000-0003-3880-4381</orcidid><orcidid>https://orcid.org/0000-0001-6924-4300</orcidid><orcidid>https://orcid.org/0000-0002-0036-3165</orcidid><orcidid>https://orcid.org/0000-0002-3012-0009</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 2020-06, Vol.130 (6), p.2845-2858
issn 0021-9738
1558-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7260031
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Antiretroviral drugs
Antiretroviral therapy
Biomedical research
Blood
Cytokines
Dendritic cells
Dendritic Cells - immunology
Dendritic Cells - pathology
Drug therapy
Female
Health aspects
Highly active antiretroviral therapy
HIV
HIV Infections - immunology
HIV Infections - pathology
HIV Infections - therapy
HIV tests
HIV-1 - physiology
Human immunodeficiency virus
Humans
Infection
Infections
Interferon regulatory factor 7
Interferon Regulatory Factor-7 - immunology
Interferon-alpha - immunology
Male
Maraviroc
NF-kappa B - immunology
NF-κB protein
Phosphorylation
Plasma
Replication
Ribonucleic acid
RNA
Scientific equipment industry
Studies
Viral infections
Viremia
Viremia - immunology
Viremia - pathology
Viremia - therapy
Virus replication
Virus Replication - immunology
Vorinostat
α-Interferon
title Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A32%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasmacytoid%20dendritic%20cells%20sense%20HIV%20replication%20before%20detectable%20viremia%20following%20treatment%20interruption&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Mitchell,%20Julie%20L&rft.aucorp=RV397,%20RV411,%20and%20RV254%20Study%20Groups&rft.date=2020-06-01&rft.volume=130&rft.issue=6&rft.spage=2845&rft.epage=2858&rft.pages=2845-2858&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI130597&rft_dat=%3Cgale_pubme%3EA627278054%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2414425187&rft_id=info:pmid/32017709&rft_galeid=A627278054&rfr_iscdi=true